The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Clinical research
Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay
Ton Heestermans1, MD, PhD; Menko-Jan de Boer2, MD, PhD; Jochem W. van Werkum3, MD, PhD; Arend Mosterd4, MD, PhD; A.T. Marcel Gosselink2, MD, PhD; Jan-Henk E. Dambrink2, MD, PhD; Gert van Houwelingen5, MD, PhD; Petra Koopmans6, MSc, PhD; Christian Hamm7, MD, PhD; Felix Zijlstra8, MD, PhD; Jurriën M. ten Berg3, MD, PhD; Arnoud W.J. van ’t Hof2*, MD, PhD
1. Department of Cardiology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands; 2. Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands; 3. Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherl
Aims: To evaluate the impact of longer duration of pre-hospital initiated antiplatelet and antithrombotic therapy on outcome in patients with ST-segment elevation myocard
Sign in to read and download the full article
Forgot your password? No account yet?
Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
myocardial infarctionglycoprotein iib/iiia receptor inhibitorsduration of pre-treatmentst-segment deviation
Read next article
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits